Advertisement
Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study

July 16, 2019

Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study

In the emergency departments of six French hospitals, Marc Blancher and team compared intranasal sufentanil versus intravenous morphine for acute severe trauma pain in a randomized, double-blind, non-inferiority trial. Read the Author Summary

Image credit: Engin_Akyurt, Pixabay

07/09/2019

Collection Review 

Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs

Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods to improve the safety and efficiency of the tuberculosis drug development process. Part of the Collection on Advances in Clinical Trial Design for Development of New Treatments for Tuberculosis.

Image credit: CNS Images, Flickr

Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again